title: In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
abstract: The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.
authors.affiliation: Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.
authors.forename: K
authors.initials: K
authors.lastname: Chirgwin
authors.forename: P M
authors.initials: PM
authors.lastname: Roblin
authors.forename: M R
authors.initials: MR
authors.lastname: Hammerschlag
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002689:Chlamydia / Q000187:drug effects*; D002690:Chlamydia Infections / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests
chemical_list: D000900:Anti-Bacterial Agents